Cerebral Sinovenous Thrombosis: 20 Years of Experience in a Pediatric Tertiary Center

Julia Loureiro Sion1, Daniele M Celeste2, Bernadete L Liphaus3,4

  • 1Pediatric Hematology Unit, Instituto Da Criança e do Adolescente, Hospital Das Clínicas, Faculdade De Medicina, Universidade De São Paulo, Sao Paulo, Brazil.

Pediatric Blood & Cancer
|September 27, 2025
PubMed

Insights

Cerebral sinovenous thrombosis (CSVT) in children is often linked to infections and dehydration. Anticoagulation treatment, though lengthy, showed good outcomes with no fatalities or recurrences in this pediatric study.

Area of Science:

  • Pediatric Neurology
  • Hematology

Background:

  • Cerebral sinovenous thrombosis (CSVT) is an uncommon but serious condition in children.
  • Identifying risk factors and optimizing treatment are crucial for pediatric CSVT management.

Purpose of the Study:

  • To analyze risk factors, treatment strategies, and outcomes of pediatric CSVT.
  • To evaluate the effectiveness and safety of anticoagulation in pediatric CSVT cases.

Main Methods:

  • Retrospective analysis of 44 pediatric CSVT cases from a 20-year registry.
  • Identification of risk factors, including infections and thrombophilia.
  • Review of anticoagulation treatments (low molecular weight heparin, unfractionated heparin) and their duration.

Main Results:

  • Risk factors were identified in 93% of cases, with infection being most common.
  • Anticoagulation was administered to 91% of patients, with treatment durations exceeding current guidelines.
  • Complete resolution of thrombi occurred in 49% of cases, with no recurrences or fatalities related to anticoagulation.

Conclusions:

  • Infections are a primary risk factor for pediatric CSVT.
  • Extended anticoagulation may be effective and safe in pediatric CSVT, despite exceeding current recommendations.
  • Pediatric CSVT patients treated with anticoagulation demonstrate favorable outcomes with high rates of thrombus resolution.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
373
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
294